Browman G[au] - Search Results

Year	Number of Results
1976	2
1977	1
1980	3
1981	1
1982	3
1983	3
1984	4
1985	8
1986	10
1987	1
1988	2
1989	5
1990	7
1991	6
1992	6
1993	7
1994	6
1995	9
1996	2
1997	5
1998	6
1999	5
2000	4
2001	9
2002	9
2003	7
2004	5
2005	6
2006	2
2007	1
2008	4
2009	2
2010	7
2011	3
2012	3
2013	1
2014	1
2015	2
2016	1
2017	1
2019	2
2020	1
2023	0

1

AGREE II: advancing guideline development, reporting and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. Brouwers MC, et al. Among authors: browman gp. CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. CMAJ. 2010. PMID: 20603348 Free PMC article. Review. No abstract available.

2

Protecting human research participants: reading vs understanding the consent form.

Holland J, Browman G, McDonald M, Saginur R. Holland J, et al. Among authors: browman g. J Natl Cancer Inst. 2013 Jul 3;105(13):927-8. doi: 10.1093/jnci/djt152. J Natl Cancer Inst. 2013. PMID: 23821756 No abstract available.

3

Cytarabine-induced palmar-plantar erythema.

Walker IR, Wilson WE, Sauder DN, Benger AM, Browman G. Walker IR, et al. Among authors: browman g. Arch Dermatol. 1985 Oct;121(10):1240-1. Arch Dermatol. 1985. PMID: 4037815 No abstract available.

4

Evidence-based clinical practice guideline development: principles, challenges, and accountability to evidence.

Browman GP. Browman GP. J Surg Oncol. 2010 Jan 1;101(1):1-2. doi: 10.1002/jso.21419. J Surg Oncol. 2010. PMID: 20025070 No abstract available.

5

Prognostic tools for cancer survival: a secondary role for quality-of-life measurement.

Browman GP, Berrang T, Smith S. Browman GP, et al. J Clin Oncol. 2009 Jun 20;27(18):2902-4. doi: 10.1200/JCO.2009.21.8438. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451423 No abstract available.

6

Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.

Browman GP. Browman GP. J Clin Oncol. 2012 Dec 1;30(34):4188-91. doi: 10.1200/JCO.2012.44.8225. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071250 No abstract available.

7

Systemic adjuvant therapy for node-negative breast cancer.

Ginsburg AD, Perrault DJ, Pritchard KI, Browman GP, McCulloch PB, Skillings J. Ginsburg AD, et al. Among authors: browman gp. CMAJ. 1989 Sep 1;141(5):381-7. CMAJ. 1989. PMID: 2670170 Free PMC article. Review.

8

Science, language, intuition, and the many meanings of quality of life.

Browman GP. Browman GP. J Clin Oncol. 1999 Jun;17(6):1651-3. doi: 10.1200/JCO.1999.17.6.1651. J Clin Oncol. 1999. PMID: 10561200 No abstract available.

9

When is a prognostic factor useful? A guide for the perplexed.

Levine MN, Browman GP, Gent M, Roberts R, Goodyear M. Levine MN, et al. Among authors: browman gp. J Clin Oncol. 1991 Feb;9(2):348-56. doi: 10.1200/JCO.1991.9.2.348. J Clin Oncol. 1991. PMID: 1988581 Review.

10

Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.

Hao D, Ritter MA, Oliver T, Browman GP. Hao D, et al. Among authors: browman gp. Semin Radiat Oncol. 2006 Jan;16(1):10-9. doi: 10.1016/j.semradonc.2005.08.002. Semin Radiat Oncol. 2006. PMID: 16378902 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results